Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 64

Viral Appropriation of Specificity Protein 1 (Sp1): The Role of Sp1 in Human Retro- and DNA Viruses in Promoter Activation and Beyond

Specificity protein 1 (Sp1) is a highly ubiquitous transcription factor and one employed by numerous viruses to complete their life cycles. In this review, we start by summarizing the relationships between Sp1 function, DNA binding, and structural motifs. We then describe the role Sp1 plays in transcriptional activation of seven viral families, composed of human retro- and DNA viruses, with a focus on key promoter regions. Additionally, we discuss pathways in common across multiple viruses, highlighting the importance of the cell regulatory role of Sp1. We also describe Sp1-related epigenetic and protein post-translational modifications during viral infection and how they relate to Sp1 binding. Finally, with these insights in mind, we comment on the potential for Sp1-targeting therapies, such as repurposing drugs currently in use in the anti-cancer realm, and what limitations such agents would have as antivirals.

Adapting Next-Generation Sequencing to in Process CRISPR-Cas9 Genome Editing of Recombinant AcMNPV Vectors: From Shotgun to Tiled-Amplicon Sequencing

The alphabaculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) is the most commonly used virus in the Baculovirus Expression Vector System (BEVS) and has been utilized for the production of many human and veterinary biologics. AcMNPV has a large dsDNA genome that remains understudied, and relatively unmodified from the wild-type, especially considering how extensively utilized it is as an expression vector. Previously, our group utilized CRISPR-Cas9 genome engineering that revealed phenotypic changes when baculovirus genes are targeted using either co-expressed sgRNA or transfected sgRNA into a stable insect cell line that produced the Cas9 protein.

The Cyborg Child: SCP-191 and the Ethics of Human Evolution

What happens when the pursuit of perfection forgets compassion?
SCP-191, known as The Cyborg Child, is one of the most haunting examples of speculative bioengineering ever documented. This essay examines the anatomy, psychology, and philosophy of a child transformed into a machine — a being caught between humanity and technology.

In this episode, we explore:

How cybernetic modification redefines the human body.

The science behind hybrid consciousness and neural integration.

The moral cost of evolution without empathy.

What SCP-191 reveals about the posthuman future.

Continue reading “The Cyborg Child: SCP-191 and the Ethics of Human Evolution” | >

An Introduction to Ebolavirus Biology

I wrote this educational primer on ebolavirus as a fun exploration of a topic not related to my current research. While such knowledge may be useful in the event of some future ebolavirus epidemic, it is mostly just an exercise in curiosity and intellectual enrichment. #virology #molecularbiology.

My website version: [ https://logancollinsblog.com/2025/11/04/an-introduction-to-ebolavirus-biology/](https://logancollinsblog.com/2025/11/04/an-introduction-to-ebolavirus-biology/)

Substack version: [ https://loganthrashercollins.substack.com/p/an-introduction-…us-biology](https://loganthrashercollins.substack.com/p/an-introduction-…us-biology)

PDF version: An Introduction to Ebolavirus Biology – Logan Thrasher Collins

I wrote this educational primer as a fun exploration of a topic not related to my current research. While such knowledge may be useful in the event of some future ebolavirus epidemic, it is mostly just an exercise in curiosity and intellectual enrichment. I hope that you too enjoy learning about this fascinating (but scary!) virus as you browse my writeup. Also, if you’re an ebolavirus expert with concepts, edits, and/or ideas to offer, feel free to reach out with your additional insights! Shoutout: I’d like to give a special shoutout/thanks to Jain et al. (reference 4) and Bodmer et al. (reference 2). I used their papers extensively throughout the creation of writeup!

Genome

Continue reading “An Introduction to Ebolavirus Biology” | >

Reactivating a fetal gene enables adult heart cells to regenerate after injury

Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart problems, like heart attacks and heart failure, the heart muscles become damaged and are difficult to treat and repair. Although many therapies have been developed to treat symptoms, full recovery to a pre-disease state has been essentially impossible. This is due to a lack of regeneration ability in adult human heart cells. Studies using stem cells or progenitor cells for repair have demonstrated limited efficacy in clinical trials, thus far.

However, there may be new hope for these patients. Researchers from the Icahn School of Medicine at Mount Sinai in New York have been working to turn back time by switching on a gene known to regenerate heart muscle cells, or cardiomyocytes. Their study, recently published in npj Regenerative Medicine, indicates that adult human hearts may be given the ability to regenerate themselves with future therapies.

Novel peanut allergy vaccine shows promise to transform allergy care

Researchers at Imperial’s National Heart & Lung Institute (NHLI) have reported encouraging results from the first phase of clinical trials for a new peanut allergy vaccine.

This vaccine aims to ‘reset’ the immune system, potentially allowing the individual to tolerate peanuts without triggering the severe allergic reactions that often occur when peanut proteins are ingested.

Phase 1 trials for a new peanut allergy vaccine show promising results, offering potential long-term relief from allergic reactions.

In collaboration with industry partner Allergy Therapeutics, the team from Imperial has developed a vaccine using virus-like particle (VLP) technology to encapsulate the peanut allergen protein Ara h2. In the latest paper, published in the Journal of Allergy and Clinical Immunology (JACI), a phase 1 first-on-human clinical trial demonstrated the VLP peanut allergy vaccine’s safety and tolerability, with no reactivity observed during skin prick tests comparing the vaccine to control treatments.

Drug-delivery patch could help to heal the heart following a heart attack

MIT engineers have developed a flexible drug-delivery patch that can be placed on the heart after a heart attack to help promote healing and regeneration of cardiac tissue.

The new patch is designed to carry several different drugs that can be released at different times, on a pre-programmed schedule. In a study of rats, the researchers showed that this treatment reduced the amount of damaged by 50% and significantly improved cardiac function.

If approved for use in humans, this type of patch could help victims recover more of their cardiac function than is now possible, the researchers say.

Rare side effects of antipsychotic medications provide new evidence for safer global prescribing

Patients with severe mental illnesses, such as schizophrenia and bipolar disorder, often require long-term use of antipsychotic medications. Some of these drugs, however, can pose potential risks, such as elevated prolactin levels and compromised immune function. Previous studies have relied mostly on small or single-center data, making it difficult to accurately assess the true incidence of rare adverse effects.

Researchers from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed), through multidisciplinary collaboration and rigorous epidemiological methods, leveraged territory-wide data from the Hospital Authority to conduct two internationally impactful studies. The findings were published in the journals World Psychiatry and The Lancet Psychiatry. These discoveries provide solid evidence for drug regulation and and establish Hong Kong as a global leader in big data research on psychiatric safety.

Protein-based gel restores dental enamel and could advance tooth repair

Scientists from the University of Nottingham’s School of Pharmacy and Department of Chemical and Environmental Engineering, in collaboration with an international team of researchers, have developed a bio-inspired material that has the potential to regenerate demineralized or eroded enamel, strengthen healthy enamel, and prevent future decay. The findings have been published in Nature Communications.

The gel can be rapidly applied to teeth in the same way dentists currently apply standard fluoride treatments. However, this new protein-based gel is fluoride free and works by mimicking key features of the natural proteins that guide the growth of dental enamel in infancy.

When applied, the gel creates a thin and robust layer that impregnates teeth, filling holes and cracks in them. It then functions as a scaffold that takes calcium and phosphate ions from saliva and promotes the controlled growth of new mineral in a process called epitaxial mineralization. This enables the new mineral to be organized and integrated into the underlying natural tissue while recovering both the structure and properties of natural healthy enamel.

/* */